We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Lilly Settles Cialis Patent Case, Delaying Generic Competition Through September 2018
Lilly Settles Cialis Patent Case, Delaying Generic Competition Through September 2018
Eli Lilly & Co. settled with several generic companies to resolve pending litigation over a unit dose patent for Cialis (tadalafil), delaying potential ANDA competition.
